Ballal Rahul D.

CIK 00018050972 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001805097

Recent Transactions

50 trades

Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-08-11+2,302→ 12,414 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-08-11−2,302→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-20−2,120→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-20+2,120→ 10,112 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-18+2,816→ 2,816 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-06-18+15,768→ 15,768 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+20,491→ 20,491 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2024-11-08−10,000→ 17,947 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-08$25.99/sh+10,000→ 17,992 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-08$58.57/sh−4,929→ 9,492 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-08$59.21/sh−1,500→ 7,992 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-08$57.24/sh−3,571→ 14,421 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-07$54.41/sh−1,868→ 7,992 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2024-11-07−10,000→ 27,947 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-07$53.32/sh−8,132→ 9,860 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-11-07$25.99/sh+10,000→ 17,992 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-10-08−4,106→ 12,322 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$28.17/sh−10,420→ 22,341 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$19.68/sh+6,314→ 28,655 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-10-08−6,314→ 69,428 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-08$5.52/sh+4,106→ 32,761 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-08-11−2,302→ 2,302 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-08-11+2,302→ 7,992 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-06-20+11,774→ 11,774 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-20+2,120→ 2,120 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13+3,388→ 5,690 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-13−3,388→ 0 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.00/sh−20,032→ 25,409 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-11−4,580→ 75,742 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$23.14/sh−30,300→ 45,441 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$12.60/sh+48,820→ 71,161 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.21/sh−3,068→ 22,341 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$19.68/sh+4,580→ 75,741 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-11−48,820→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-10$12.60/sh+13,600→ 35,941 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-10$21.01/sh−13,600→ 22,341 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-10−13,600→ 48,820 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-04$19.15/sh−3,485→ 22,341 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-04$12.60/sh+3,485→ 25,826 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-04−3,485→ 62,420 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-01$12.60/sh+94→ 22,435 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-01$5.52/sh+3,143→ 25,578 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-01$19.08/sh−3,237→ 22,341 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-01−94→ 65,905 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-01−3,143→ 16,428 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-03-20$5.52/sh+13,278→ 35,619 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-03-20$19.16/sh−13,278→ 22,341 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-03-20−13,278→ 19,571 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+16,835→ 16,835 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+23,364→ 23,364 total

Companies

Recent Filings

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov